BenevolentAI delists and merges with Osaka Holdings

BenevolentAI, a pioneer in AI-driven drug discovery with Cambridge facilities at Babraham Hall, is demerging from Euronext Amsterdam via a merger with Japanese-owned Osaka Holdings. The move will …
( read original story …)

---